Key result
Intradialytic hypertension affects 10-15% of hemodialysis patients and is associated with increased mortality, prompting recent studies into various pharmacological and nonpharmacological treatments.
Why the study?
Intradialytic hypertension associates with increased cardiovascular and all-cause mortality, and recent attempts have emerged to examine nonpharmacological and pharmacological measures after a historical scarcity of treatment studies.
This review summarizes current evidence on the pathophysiology and management of intradialytic hypertension, highlighting the need for further research.
Answers are grounded in this paper and cite their sources.
Intradialytic hypertension warrants clinical vigilance in hemodialysis; leaves open optimal management strategies for prospective trials.
Intradialytic hypertension (IDH), that is, a paradoxical rise in blood pressure (BP) during or immediately after a hemodialysis session, affects approximately 10-15% of the hemodialysis population. It is currently recognized as a phenomenon of major clinical significance as recent studies have shown that BP elevation extends to the whole interdialytic interval and associates with increased cardiovascular and all-cause mortality. The pathophysiology of IDH is complex involving volume and sodium overload, endothelial dysfunction, excess renin-angiotensin-aldosterone system and sympathetic nervous system activation, and other mechanisms. For several years, there was a scarcity of studies regarding IDH treatment; recently, however, several attempts to examine the effect of nonpharmacological and pharmacological measures on BP levels in IDH are made. This review attempts to summarize this latest evidence in the field of management of IDH and discuss areas for future research.
No takes yet. Share an insight, caveat, or question.
Iatridi et al. (2022) conducted a review in Intradialytic hypertension. Nonpharmacological and pharmacological measures was evaluated. Intradialytic hypertension affects 10-15% of hemodialysis patients and is associated with increased mortality, prompting recent studies into various pharmacological and nonpharmacological treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: